vs
ALLURION TECHNOLOGIES, INC.（ALUR）与Apyx Medical Corp（APYX）财务数据对比。点击上方公司名可切换其他公司
Apyx Medical Corp的季度营收约是ALLURION TECHNOLOGIES, INC.的5.3倍（$19.2M vs $3.6M）。Apyx Medical Corp净利率更高（-6.8% vs -167.0%，领先160.3%）。Apyx Medical Corp同比增速更快（34.7% vs -35.4%）。过去两年Apyx Medical Corp的营收复合增速更高（36.8% vs -38.0%）
罗宾逊科技是一家日本电子游戏开发商，由塞思·罗宾逊创立。该公司开发了《赤龙传说》、《行星：太空探索》等BBS门户游戏，还与Hamumu Software合作开发了实验性多人创意沙盒游戏《成长国度》，该作于2013年在iOS、安卓、Windows和macOS平台推出。
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
ALUR vs APYX — 直观对比
营收规模更大
APYX
是对方的5.3倍
$3.6M
营收增速更快
APYX
高出70.1%
-35.4%
净利率更高
APYX
高出160.3%
-167.0%
两年增速更快
APYX
近两年复合增速
-38.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6M | $19.2M |
| 净利润 | $-6.0M | $-1.3M |
| 毛利率 | 44.5% | 62.6% |
| 营业利润率 | -174.2% | 0.1% |
| 净利率 | -167.0% | -6.8% |
| 营收同比 | -35.4% | 34.7% |
| 净利润同比 | 37.2% | 71.9% |
| 每股收益（稀释后） | $-0.69 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALURAPYX
| Q4 25 | $3.6M | $19.2M | ||
| Q3 25 | $2.7M | $12.9M | ||
| Q2 25 | $3.4M | $11.4M | ||
| Q1 25 | $5.6M | $9.4M | ||
| Q4 24 | $5.6M | $14.2M | ||
| Q3 24 | $5.4M | $11.5M | ||
| Q2 24 | $11.8M | $12.1M | ||
| Q1 24 | $9.4M | $10.2M |
净利润ALURAPYX
| Q4 25 | $-6.0M | $-1.3M | ||
| Q3 25 | $-11.9M | $-2.0M | ||
| Q2 25 | $-9.3M | $-3.8M | ||
| Q1 25 | $-1.5M | $-4.2M | ||
| Q4 24 | $-9.6M | $-4.6M | ||
| Q3 24 | $8.7M | $-4.7M | ||
| Q2 24 | $-8.3M | $-6.6M | ||
| Q1 24 | $2.0M | $-7.6M |
毛利率ALURAPYX
| Q4 25 | 44.5% | 62.6% | ||
| Q3 25 | 49.1% | 64.4% | ||
| Q2 25 | 73.9% | 62.3% | ||
| Q1 25 | 74.6% | 60.1% | ||
| Q4 24 | 45.3% | 63.0% | ||
| Q3 24 | 58.0% | 60.5% | ||
| Q2 24 | 76.4% | 61.7% | ||
| Q1 24 | 73.2% | 58.1% |
营业利润率ALURAPYX
| Q4 25 | -174.2% | 0.1% | ||
| Q3 25 | -362.3% | -6.5% | ||
| Q2 25 | -205.7% | -22.6% | ||
| Q1 25 | -130.5% | -32.4% | ||
| Q4 24 | -306.2% | -21.4% | ||
| Q3 24 | -229.9% | -31.6% | ||
| Q2 24 | -79.4% | -45.7% | ||
| Q1 24 | -121.4% | -64.6% |
净利率ALURAPYX
| Q4 25 | -167.0% | -6.8% | ||
| Q3 25 | -447.1% | -15.4% | ||
| Q2 25 | -276.3% | -33.2% | ||
| Q1 25 | -26.9% | -44.0% | ||
| Q4 24 | -171.8% | -32.5% | ||
| Q3 24 | 162.8% | -40.9% | ||
| Q2 24 | -70.7% | -54.0% | ||
| Q1 24 | 21.3% | -74.0% |
每股收益（稀释后）ALURAPYX
| Q4 25 | $-0.69 | — | ||
| Q3 25 | $-1.53 | — | ||
| Q2 25 | $-1.28 | — | ||
| Q1 25 | $-0.31 | — | ||
| Q4 24 | $-3.22 | — | ||
| Q3 24 | $3.40 | — | ||
| Q2 24 | $-4.34 | $-0.19 | ||
| Q1 24 | $0.96 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.4M | $31.7M |
| 总债务越低越好 | — | $37.5M |
| 股东权益账面价值 | $-77.2M | $14.5M |
| 总资产 | $15.8M | $66.8M |
| 负债/权益比越低杠杆越低 | — | 2.58× |
8季度趋势，按日历期对齐
现金及短期投资ALURAPYX
| Q4 25 | $5.4M | $31.7M | ||
| Q3 25 | $6.1M | $25.1M | ||
| Q2 25 | $12.7M | $29.3M | ||
| Q1 25 | $20.4M | $31.0M | ||
| Q4 24 | $15.4M | $31.7M | ||
| Q3 24 | $28.7M | $28.0M | ||
| Q2 24 | $19.3M | $32.7M | ||
| Q1 24 | $29.7M | $37.3M |
总债务ALURAPYX
| Q4 25 | — | $37.5M | ||
| Q3 25 | — | $37.5M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | — | $37.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALURAPYX
| Q4 25 | $-77.2M | $14.5M | ||
| Q3 25 | $-82.9M | $5.8M | ||
| Q2 25 | $-64.0M | $7.3M | ||
| Q1 25 | $-69.8M | $10.5M | ||
| Q4 24 | $-78.0M | $14.2M | ||
| Q3 24 | $-64.8M | $11.0M | ||
| Q2 24 | $-70.6M | $14.7M | ||
| Q1 24 | $-66.2M | $20.3M |
总资产ALURAPYX
| Q4 25 | $15.8M | $66.8M | ||
| Q3 25 | $18.1M | $57.4M | ||
| Q2 25 | $28.2M | $58.2M | ||
| Q1 25 | $38.4M | $60.2M | ||
| Q4 24 | $32.8M | $64.8M | ||
| Q3 24 | $50.7M | $60.7M | ||
| Q2 24 | $46.5M | $65.4M | ||
| Q1 24 | $60.0M | $70.7M |
负债/权益比ALURAPYX
| Q4 25 | — | 2.58× | ||
| Q3 25 | — | 6.41× | ||
| Q2 25 | — | 5.17× | ||
| Q1 25 | — | 3.57× | ||
| Q4 24 | — | 2.64× | ||
| Q3 24 | — | 3.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.8M |
| 自由现金流率自由现金流/营收 | — | -14.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-9.1M |
8季度趋势，按日历期对齐
经营现金流ALURAPYX
| Q4 25 | $-5.3M | $-2.5M | ||
| Q3 25 | $-6.5M | $-3.5M | ||
| Q2 25 | $-7.6M | $-1.2M | ||
| Q1 25 | $-9.5M | $-702.0K | ||
| Q4 24 | $-13.3M | $-2.9M | ||
| Q3 24 | $-11.5M | $-4.4M | ||
| Q2 24 | $-8.9M | $-4.3M | ||
| Q1 24 | $-8.6M | $-6.3M |
自由现金流ALURAPYX
| Q4 25 | — | $-2.8M | ||
| Q3 25 | — | $-4.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-757.0K | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | $-11.5M | $-4.6M | ||
| Q2 24 | $-9.4M | $-4.6M | ||
| Q1 24 | $-8.7M | $-6.4M |
自由现金流率ALURAPYX
| Q4 25 | — | -14.6% | ||
| Q3 25 | — | -31.5% | ||
| Q2 25 | — | -13.2% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | — | -22.4% | ||
| Q3 24 | -214.9% | -40.0% | ||
| Q2 24 | -79.6% | -38.0% | ||
| Q1 24 | -93.1% | -62.2% |
资本支出强度ALURAPYX
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 3.7% | 2.4% | ||
| Q1 24 | 1.1% | 0.3% |
现金转化率ALURAPYX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -4.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
